250 – Evaluation Within 30 Days of Referral Using Telehealth Expedites Listing and Decreases Mortality in Patients Referred for Liver Transplantation

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

“…Another Korean study also demonstrated that 5% of BCLC stage A (six of 119) and 1.4% of BCLC stage B (one of 71) HCC patients were shifted to BCLC stage C after identifying extrahepatic lesions using FDG PET-CT. 222 An U.S. cohort study of 101 treatment-naïve patients reported changes of BCLC staging and treatment strategy in 5.9% and 9.9%, respectively, of the patients by adding FDG PET-CT after initial staging with contrast-enhanced CT or MRI. 223 Also, dual tracer PET-CT ( 18 F-fluorocholine and FDG PET-CT) detected new lesions in 26 patients (21%), updated the BCLC stage in 14 (11%), and modified treatment strategy in 17 (14%), compared to conventional imaging alone, in a retrospective cohort of 122 HCC patients from France. 224 Hence, FDG PET-CT may be selectively considered for patients with HCC prior to curative surgical treatments, such as hepatic resection and LT.…”